180 Life Sciences News - ATNF

Company Name	Stock Ticker Symbol	Market	Type
180 Life Sciences Corporation	ATNF	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.04	2.11%	1.94	08:14:13

Open Price	Low Price	High Price	Close Price	Prev Close
				1.90

more quote information »

Recent News

Date	Time	Source	Heading
3/14/2024	08:30	GLOBE	180 Life Sciences Regains Full Compliance with Nasdaq ..
3/11/2024	07:03	EDGAR2	Form 8-K - Current report
3/08/2024	16:49	EDGAR2	Form 8-K - Current report
2/29/2024	08:00	EDGAR2	Form 8-K - Current report
2/28/2024	06:42	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
2/28/2024	06:39	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
2/28/2024	06:37	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
2/28/2024	06:30	EDGAR2	Form 8-K - Current report
2/26/2024	07:00	EDGAR2	Form 8-K - Current report
2/26/2024	07:00	GLOBE	180 Life Sciences Corp. Announces 1-For 19 Reverse Stock..
2/20/2024	08:01	EDGAR2	Form 8-K - Current report
2/16/2024	17:10	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
2/16/2024	17:08	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
2/16/2024	17:05	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
2/16/2024	16:15	EDGAR2	Form 8-K - Current report
2/12/2024	16:15	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
1/31/2024	17:29	EDGAR2	Form S-1 - General form for registration of securities under..
1/29/2024	08:00	EDGAR2	Form 8-K - Current report
1/17/2024	08:30	EDGAR2	Form 8-K - Current report
1/16/2024	08:30	EDGAR2	Form 8-K - Current report
12/28/2023	18:42	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/27/2023	16:15	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
12/26/2023	16:15	EDGAR2	Form DEF 14A - Other definitive proxy statements
12/21/2023	17:00	EDGAR2	Form 8-K - Current report
12/20/2023	08:00	EDGAR2	Form 8-K - Current report
12/18/2023	16:15	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/15/2023	08:30	EDGAR2	Form 8-K - Current report
12/14/2023	16:30	EDGAR2	Form PRE 14A - Other preliminary proxy statements
12/04/2023	09:00	EDGAR2	Form 8-K - Current report
12/04/2023	09:00	GLOBE	180 Life Sciences Engages Financial Advisor to Explore..
11/30/2023	17:31	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
11/30/2023	17:29	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
11/29/2023	08:10	EDGAR2	Form 8-K - Current report
11/28/2023	09:00	EDGAR2	Form 8-K - Current report
11/28/2023	09:00	GLOBE	180 Life Sciences Announces Review of Strategic Alternatives
11/16/2023	16:30	EDGAR2	Form 8-K - Current report
11/09/2023	17:00	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/18/2023	16:33	EDGAR2	Form 8-K - Current report
10/13/2023	17:00	EDGAR2	Form 8-K - Current report
9/28/2023	16:18	EDGAR2	Form 8-K - Current report
9/22/2023	09:00	EDGAR2	Form 8-K - Current report
9/08/2023	16:30	EDGAR2	Form 8-K - Current report
9/08/2023	16:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/08/2023	16:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/07/2023	08:30	EDGAR2	Form 8-K - Current report
9/06/2023	18:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/06/2023	18:28	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/30/2023	16:56	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
8/15/2023	17:27	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
8/15/2023	17:26	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]